Cargando…

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study

BACKGROUND AND AIM: Patients with chronic diseases are believed to be at increased risk of mental health conditions during the COVID‐19 pandemic. We aimed to assess the incidence of psychological morbidity in inflammatory bowel disease (IBD) patients during the COVID‐19 pandemic, explore for associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Luber, Raphael P, Duff, Alexa, Pavlidis, Polychronis, Honap, Sailish, Meade, Susanna, Ray, Shuvra, Anderson, Simon H, Mawdsley, Joel, Samaan, Mark A, Irving, Peter M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762622/
https://www.ncbi.nlm.nih.gov/pubmed/35071792
http://dx.doi.org/10.1002/jgh3.12699
_version_ 1784633800426258432
author Luber, Raphael P
Duff, Alexa
Pavlidis, Polychronis
Honap, Sailish
Meade, Susanna
Ray, Shuvra
Anderson, Simon H
Mawdsley, Joel
Samaan, Mark A
Irving, Peter M
author_facet Luber, Raphael P
Duff, Alexa
Pavlidis, Polychronis
Honap, Sailish
Meade, Susanna
Ray, Shuvra
Anderson, Simon H
Mawdsley, Joel
Samaan, Mark A
Irving, Peter M
author_sort Luber, Raphael P
collection PubMed
description BACKGROUND AND AIM: Patients with chronic diseases are believed to be at increased risk of mental health conditions during the COVID‐19 pandemic. We aimed to assess the incidence of psychological morbidity in inflammatory bowel disease (IBD) patients during the COVID‐19 pandemic, explore for association with risk of severe COVID‐19 and other factors, and establish patients' interest in psychological support. METHODS: A survey including the Patient Health Questionnaire‐9, General Anxiety Disorder‐7, and Perceived Stress Scale tools for depression, anxiety, and stress was administered to IBD patients from a tertiary center in London, United Kingdom, in June 2020. RESULTS: Two hundred seventy‐four patients responded to the survey (57% response rate), with 271 (99%) completing it. Moderate–severe depression was observed in 61 (22.5%), while 49 (18%) had moderate–severe anxiety; 39 (14%) had both diagnoses. Mean (SD) stress score was 16.2 (7.4). There was no association between degree of severe COVID‐19 risk and psychological morbidity. Flare symptoms and fatigue were associated with worse psychological morbidity, while accessibility of information regarding COVID‐19 risk and reducing that risk was protective for depression (odds ratio [OR] 0.56 [0.33–0.94], P = 0.03), anxiety (OR 0.62 [0.4–0.96], P = 0.03), and stress (standardized β‐coefficient −0.15 [−0.28 to −0.03], P = 0.02). Seventy‐nine (30%) respondents were interested in receiving psychological support during the pandemic, while 200 (76%) expressed interest beyond the pandemic. CONCLUSIONS: Although depression, anxiety, and stress among IBD patients during the pandemic were common, their frequency was similar to pre‐pandemic rates and recent general population levels. Ensuring easy access to personalized risk information with targeted psychological support may mitigate psychological burden as patients reintegrate into society and deal with future COVID‐19 waves.
format Online
Article
Text
id pubmed-8762622
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-87626222022-01-21 Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study Luber, Raphael P Duff, Alexa Pavlidis, Polychronis Honap, Sailish Meade, Susanna Ray, Shuvra Anderson, Simon H Mawdsley, Joel Samaan, Mark A Irving, Peter M JGH Open Original Articles BACKGROUND AND AIM: Patients with chronic diseases are believed to be at increased risk of mental health conditions during the COVID‐19 pandemic. We aimed to assess the incidence of psychological morbidity in inflammatory bowel disease (IBD) patients during the COVID‐19 pandemic, explore for association with risk of severe COVID‐19 and other factors, and establish patients' interest in psychological support. METHODS: A survey including the Patient Health Questionnaire‐9, General Anxiety Disorder‐7, and Perceived Stress Scale tools for depression, anxiety, and stress was administered to IBD patients from a tertiary center in London, United Kingdom, in June 2020. RESULTS: Two hundred seventy‐four patients responded to the survey (57% response rate), with 271 (99%) completing it. Moderate–severe depression was observed in 61 (22.5%), while 49 (18%) had moderate–severe anxiety; 39 (14%) had both diagnoses. Mean (SD) stress score was 16.2 (7.4). There was no association between degree of severe COVID‐19 risk and psychological morbidity. Flare symptoms and fatigue were associated with worse psychological morbidity, while accessibility of information regarding COVID‐19 risk and reducing that risk was protective for depression (odds ratio [OR] 0.56 [0.33–0.94], P = 0.03), anxiety (OR 0.62 [0.4–0.96], P = 0.03), and stress (standardized β‐coefficient −0.15 [−0.28 to −0.03], P = 0.02). Seventy‐nine (30%) respondents were interested in receiving psychological support during the pandemic, while 200 (76%) expressed interest beyond the pandemic. CONCLUSIONS: Although depression, anxiety, and stress among IBD patients during the pandemic were common, their frequency was similar to pre‐pandemic rates and recent general population levels. Ensuring easy access to personalized risk information with targeted psychological support may mitigate psychological burden as patients reintegrate into society and deal with future COVID‐19 waves. Wiley Publishing Asia Pty Ltd 2022-01-05 /pmc/articles/PMC8762622/ /pubmed/35071792 http://dx.doi.org/10.1002/jgh3.12699 Text en © 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Luber, Raphael P
Duff, Alexa
Pavlidis, Polychronis
Honap, Sailish
Meade, Susanna
Ray, Shuvra
Anderson, Simon H
Mawdsley, Joel
Samaan, Mark A
Irving, Peter M
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study
title Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study
title_full Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study
title_fullStr Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study
title_full_unstemmed Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study
title_short Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study
title_sort depression, anxiety, and stress among inflammatory bowel disease patients during covid‐19: a uk cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762622/
https://www.ncbi.nlm.nih.gov/pubmed/35071792
http://dx.doi.org/10.1002/jgh3.12699
work_keys_str_mv AT luberraphaelp depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT duffalexa depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT pavlidispolychronis depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT honapsailish depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT meadesusanna depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT rayshuvra depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT andersonsimonh depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT mawdsleyjoel depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT samaanmarka depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy
AT irvingpeterm depressionanxietyandstressamonginflammatoryboweldiseasepatientsduringcovid19aukcohortstudy